Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Chronic Heart Failure

  Free Subscription


Articles published in Lancet

Retrieve available abstracts of 24 articles:
HTML format
Text format



Single Articles


    March 2019
  1. BAX JJ, Di Carli M, Narula J, Delgado V, et al
    Multimodality imaging in ischaemic heart failure.
    Lancet. 2019;393:1056-1070.
    PubMed     Text format     Abstract available


  2. NORMAND C, Kaye DM, Povsic TJ, Dickstein K, et al
    Beyond pharmacological treatment: an insight into therapies that target specific aspects of heart failure pathophysiology.
    Lancet. 2019;393:1045-1055.
    PubMed     Text format     Abstract available


  3. ROSSIGNOL P, Hernandez AF, Solomon SD, Zannad F, et al
    Heart failure drug treatment.
    Lancet. 2019;393:1034-1044.
    PubMed     Text format     Abstract available


    February 2019
  4. BARGE-CABALLERO G, Gargallo-Fernandez P, Barge-Caballero E, Crespo-Leiro MG, et al
    Popeye's sign, heart disease, and amyloidosis.
    Lancet. 2019;393:e32.
    PubMed     Text format    


    November 2018
  5. WILCOX J, Yancy CW
    Stopping medication for heart failure with improved ejection fraction.
    Lancet. 2018 Nov 9. pii: S0140-6736(18)32825.
    PubMed     Text format    


  6. HALLIDAY BP, Wassall R, Lota AS, Khalique Z, et al
    Withdrawal of pharmacological treatment for heart failure in patients with recovered dilated cardiomyopathy (TRED-HF): an open-label, pilot, randomised trial.
    Lancet. 2018 Nov 9. pii: S0140-6736(18)32484.
    PubMed     Text format     Abstract available


    August 2018
  7. CLELAND JFG, Clark RA
    Telehealth: delivering high-quality care for heart failure.
    Lancet. 2018 Aug 24. pii: S0140-6736(18)31995.
    PubMed     Text format    


  8. KOEHLER F, Koehler K, Deckwart O, Prescher S, et al
    Efficacy of telemedical interventional management in patients with heart failure (TIM-HF2): a randomised, controlled, parallel-group, unmasked trial.
    Lancet. 2018 Aug 24. pii: S0140-6736(18)31880.
    PubMed     Text format     Abstract available


  9. THE LANCET
    Heart failure: the need for improved treatment and care.
    Lancet. 2018;392:451.
    PubMed     Text format    


    June 2018
  10. PATEL T, Tesfaldet B, Chowdhury I, Kettermann A, et al
    Endpoints in diabetes cardiovascular outcome trials.
    Lancet. 2018;391:2412.
    PubMed     Text format    


    March 2018
  11. DZIADZKO V, Clavel MA, Dziadzko M, Medina-Inojosa JR, et al
    Outcome and undertreatment of mitral regurgitation: a community cohort study.
    Lancet. 2018;391:960-969.
    PubMed     Text format     Abstract available


  12. MCKELLAR S
    The promissory nature of artificial hearts.
    Lancet. 2018;391:930-931.
    PubMed     Text format    


    November 2017
  13. THE LANCET
    Heart failure in an ageing population.
    Lancet. 2017 Nov 22. pii: S0140-6736(17)33039.
    PubMed     Text format    


  14. CONRAD N, Judge A, Tran J, Mohseni H, et al
    Temporal trends and patterns in heart failure incidence: a population-based study of 4 million individuals.
    Lancet. 2017 Nov 21. pii: S0140-6736(17)32520.
    PubMed     Text format     Abstract available


  15. ZANNAD F
    Rising incidence of heart failure demands action.
    Lancet. 2017 Nov 21. pii: S0140-6736(17)32873.
    PubMed     Text format    


    April 2017
  16. METRA M, Teerlink JR
    Heart failure.
    Lancet. 2017 Apr 28. pii: S0140-6736(17)31071.
    PubMed     Text format     Abstract available


    January 2017
  17. LEAUTE-LABREZE C, Harper JI, Hoeger PH
    Infantile haemangioma.
    Lancet. 2017 Jan 12. pii: S0140-6736(16)00645.
    PubMed     Text format     Abstract available


    December 2016
  18. SLIWA K
    The heart of Africa: succeeding against the odds.
    Lancet. 2016;388:e28-e36.
    PubMed     Text format     Abstract available


  19. PACKER M, McMurray JJ
    Importance of endogenous compensatory vasoactive peptides in broadening the effects of inhibitors of the renin-angiotensin system for the treatment of heart failure.
    Lancet. 2016 Dec 2. pii: S0140-6736(16)30969.
    PubMed     Text format     Abstract available


    November 2016
  20. TEERLINK JR, Felker GM, McMurray JJ, Solomon SD, et al
    Chronic Oral Study of Myosin Activation to Increase Contractility in Heart Failure (COSMIC-HF): a phase 2, pharmacokinetic, randomised, placebo-controlled trial.
    Lancet. 2016 Nov 30. pii: S0140-6736(16)32049.
    PubMed     Text format     Abstract available


  21. RODES-CABAU J, Taramasso M, O'Gara PT
    Diagnosis and treatment of tricuspid valve disease: current and future perspectives.
    Lancet. 2016;388:2431-2442.
    PubMed     Text format     Abstract available


    August 2016
  22. PICCINI JP, Fauchier L
    Rhythm control in atrial fibrillation.
    Lancet. 2016;388:829-840.
    PubMed     Text format     Abstract available


  23. VAN GELDER IC, Rienstra M, Crijns HJ, Olshansky B, et al
    Rate control in atrial fibrillation.
    Lancet. 2016;388:818-828.
    PubMed     Text format     Abstract available


    February 2016
  24. BLACHER J, Levy BI, Mourad JJ, Safar ME, et al
    From epidemiological transition to modern cardiovascular epidemiology: hypertension in the 21st century.
    Lancet. 2016 Feb 5. pii: S0140-6736(16)00002.
    PubMed     Text format    


Thank you for your interest in scientific medicine.


AMEDEO Chronic Heart Failure is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: